Similarly, in the study from Rodriguez-Garcia et al., infusion of FRβ-specific CAR-T cells resulted in depletion of FRβ+ TAMs and controlled tumor progression in ovarian cancer, melanoma and colon adenocarcinoma (204). This evidence concerns the gene FOLR2 and colon adenocarcinoma.